These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 34497362

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Association of Ultrasonography Features of Follicular Thyroid Carcinoma With Tumor Invasiveness and Prognosis Based on WHO Classification and TERT Promoter Mutation.
    Kim MK, Park H, Oh YL, Shin JH, Kim TH, Hahn SY.
    Korean J Radiol; 2024 Jan; 25(1):103-112. PubMed ID: 38184773
    [Abstract] [Full Text] [Related]

  • 3. Selection Criteria for Completion Thyroidectomy in Follicular Thyroid Carcinoma Using Primary Tumor Size and TERT Promoter Mutational Status.
    Park H, Heo J, Ki CS, Shin JH, Oh YL, Son YI, Kim JS, Kim SW, Chung JH, Kim TY, Kim TH, Kim JH.
    Ann Surg Oncol; 2023 May; 30(5):2916-2925. PubMed ID: 36637642
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. TERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological characteristics of thyroid cancer.
    Liu X, Qu S, Liu R, Sheng C, Shi X, Zhu G, Murugan AK, Guan H, Yu H, Wang Y, Sun H, Shan Z, Teng W, Xing M.
    J Clin Endocrinol Metab; 2014 Jun; 99(6):E1130-6. PubMed ID: 24617711
    [Abstract] [Full Text] [Related]

  • 6. Clinical Outcomes and Implications of Radioactive Iodine Therapy on Cancer-specific Survival in WHO Classification of FTC.
    Li G, Ye Z, Wei T, Zhu J, Li Z, Lei J.
    J Clin Endocrinol Metab; 2024 Aug 13; 109(9):2294-2305. PubMed ID: 38436929
    [Abstract] [Full Text] [Related]

  • 7. Mutation profiles of follicular thyroid tumors by targeted sequencing.
    Duan H, Liu X, Ren X, Zhang H, Wu H, Liang Z.
    Diagn Pathol; 2019 May 10; 14(1):39. PubMed ID: 31077238
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Refining Dynamic Risk Stratification and Prognostic Groups for Differentiated Thyroid Cancer With TERT Promoter Mutations.
    Kim TH, Ki CS, Kim HS, Kim K, Choe JH, Kim JH, Kim JS, Oh YL, Hahn SY, Shin JH, Jang HW, Kim SW, Chung JH.
    J Clin Endocrinol Metab; 2017 May 01; 102(5):1757-1764. PubMed ID: 28323925
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. TERT Promoter Mutation Spatial Heterogeneity in a Metastatic Follicular Thyroid Carcinoma: Implications for Clinical Work-Up.
    Stenman A, Hysek M, Jatta K, Bränström R, Darai-Ramqvist E, Paulsson JO, Wang N, Larsson C, Zedenius J, Juhlin CC.
    Endocr Pathol; 2019 Sep 01; 30(3):246-248. PubMed ID: 31154561
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prognostic Significance of TERT Promoter Mutations in Papillary Thyroid Carcinomas in a BRAF(V600E) Mutation-Prevalent Population.
    Lee SE, Hwang TS, Choi YL, Han HS, Kim WS, Jang MH, Kim SK, Yang JH.
    Thyroid; 2016 Jul 01; 26(7):901-10. PubMed ID: 27184112
    [Abstract] [Full Text] [Related]

  • 18. TERT promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA.
    Wang N, Liu T, Sofiadis A, Juhlin CC, Zedenius J, Höög A, Larsson C, Xu D.
    Cancer; 2014 Oct 01; 120(19):2965-79. PubMed ID: 24898513
    [Abstract] [Full Text] [Related]

  • 19. Prognostic significance of patient age in minimally and widely invasive follicular thyroid carcinoma: investigation of three age groups.
    Ito Y, Miyauchi A, Tomoda C, Hirokawa M, Kobayashi K, Miya A.
    Endocr J; 2014 Oct 01; 61(3):265-71. PubMed ID: 24390055
    [Abstract] [Full Text] [Related]

  • 20. Effect of single-nucleotide polymorphism in TERT promoter on follicular thyroid tumor development.
    Hirokawa T, Arimasu Y, Nakazato Y, Chiba T, Fujiwara M, Kamma H.
    Pathol Int; 2020 Apr 01; 70(4):210-216. PubMed ID: 31943533
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.